Chip Clark
Chairman at IBIO, INC.
Net worth: 1 470 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mihael Polymeropoulos | M | 64 | 22 years | |
| Marc Banjak | M | - | - | |
| Mike Jenkins | M | - | - | |
| Felipe Duran | M | 45 | 3 years | |
| Linda Armstrong | M | 61 | 4 years | |
| Gary Sender | M | 62 | 4 years | |
| James Hill | M | 78 | 16 years | |
| Evert Schimmelpennink | M | 52 | 3 years | |
| Martin Brenner | M | 54 | 3 years | |
| Richard W. Dugan | M | 82 | 19 years | |
| Alexandra Kropotova | M | 51 | 4 years | |
| Phan Dillon | M | - | - | |
| Matthew Luter | M | - | - | |
| Deepak Shripad Phadke | M | 73 | 19 years | |
| Nick DeLong | M | - | - | |
| Lisa Middlebrook | F | - | 3 years | |
| Stephen Kilmer | M | - | - | |
| Gunther Birznieks | M | 55 | 21 years | |
| Susan Thomas | F | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Gray | M | 53 |
Arsanis, Inc.
 Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | 3 years |
| Robert Kay | M | 83 | 14 years | |
| René Russo | M | 49 |
Arsanis, Inc.
Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | 4 years |
| Stephanie R. Irish | F | 53 | 5 years | |
| Tillman Gerngross | M | 60 |
Arsanis, Inc.
Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | 9 years |
| Paula Ragan | M | 54 |
Arsanis, Inc.
Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | - |
| Argeris Karabelas | M | 71 | 10 years | |
| Thomas F. Isett | M | 59 | 3 years | |
| Howard H. Pien | M | 66 | 9 years | |
| H. Watkins | M | 71 | 16 years | |
| Seymour Flug | M | 88 | 9 years | |
| Steven Shallcross | M | 62 | 4 years | |
| Glenn J. Chang | M | 76 | 14 years | |
| Michael Ross | M | 75 |
Arsanis, Inc.
Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | 8 years |
| Adam Mostafa | M | 44 |
Arsanis, Inc.
Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | - |
| Carl Gordon | M | 59 |
Arsanis, Inc.
Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | 9 years |
| Amy Schulman | F | 63 |
Arsanis, Inc.
Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | 4 years |
| Claudio Nessi | M | 56 |
Arsanis, Inc.
Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | 6 years |
| Chris Stevens | M | 65 |
Arsanis, Inc.
Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | 3 years |
| Bob R. Seltzer | M | 48 |
Care Capital LLC
 Care Capital LLC Investment ManagersFinance Care Capital LLC (care capital) is a venture capital firm founded in 2001 by Jan Leschly and David Ramsay. The firm is headquartered in Princeton, New Jersey. | 10 years |
| Robert M. Lutz | M | 55 | 9 years | |
| James Tananbaum | M | 60 | 3 years | |
| John Joseph Feeney | M | 68 | - | |
| Albert W. Gianchetti | M | 59 | 1 years | |
| Frederick H. Graff | M | - | 2 years | |
| Todd Horich | M | - | 3 years | |
| Isaac Blech | M | 73 |
Arsanis, Inc.
Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | - |
| Paolo Baroldi | M | 73 | 3 years | |
| Randy Maddux | M | 62 | 2 years | |
| Wayne T. Hockmeyer | M | 79 | 2 years | |
| Thomas Lyle Copmann | M | 71 | 2 years | |
| Marino Carol | F | - |
Care Capital LLC
Care Capital LLC Investment ManagersFinance Care Capital LLC (care capital) is a venture capital firm founded in 2001 by Jan Leschly and David Ramsay. The firm is headquartered in Princeton, New Jersey. | 1 years |
| Michael Wyzga | M | 69 |
Arsanis, Inc.
Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | - |
| Brian Halak | M | 52 | 6 years | |
| Jessica L. Archibald | F | - |
Care Capital LLC
Care Capital LLC Investment ManagersFinance Care Capital LLC (care capital) is a venture capital firm founded in 2001 by Jan Leschly and David Ramsay. The firm is headquartered in Princeton, New Jersey. | - |
| David Ramsay | M | 60 | 6 years | |
| Jan Smilek | M | 57 | 2 years | |
| Terry McGuire | M | 68 |
Arsanis, Inc.
Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | 8 years |
| Gary Bridger | M | 61 |
Arsanis, Inc.
Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 58 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Chip Clark
- Personal Network
